Agitation in Alzheimer’s Disease: What We Know and Where We’re Going
Alzheimer’s disease-associated behavioral symptoms such as agitation are particularly distressful and burdensome for patients and care partners, and they are…
Related Articles
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
On December 16, the FDA approved tapinarof (Vtama) cream 1% for individuals with atopic dermatitis aged 2 years and older. The approval followed the conclusi…
Community‐based epilepsy care in an onchocerciasis‐endemic area: A 3‐year cohort study in Mahenge, Tanzania
Objective In onchocerciasis-endemic areas, limited access to antiseizure medications (ASMs) contributes to a high epilepsy burden. This study evaluated the impact of a community-based epilepsy…
Symptom Network Analysis in a Large Sample of Children and Adults with a Chronic Tic Disorder
Background Chronic tic disorders (CTD) are multifaceted disorders characterized by multiple motor and/or vocal tics. They are often associated with complex tics including echophenomena, paliphenomen…
Early initiation of intravenous cyclophosphamide and one‐year outcome in super‐refractory cryptogenic‐new onset refractory status epilepticus
To explore the potential efficacy of early initiation of intravenous cyclophosphamide (IVCPA), we reviewed consecutive four cases of super-refractory cryptogenic-new onset refractory status epilepti…
2024 Written Board Review Course
Join us for CNS’ SANS Written Board Review Course held virtually January 27, 2024. Expert faculty provide comprehensive preparation for the ABNS Primary Exam through…
Analysis of practical judgment in older adults with epilepsy: An exploratory, multicenter cohort study
Despite the high prevalence of cognitive deficits in older people with epilepsy (PWE), their ability to judge and make decisions in daily life remains unexplored.…
EAN Advocacy Training
Under the umbrella of the Brain Health Mission, and as a way to support its 48 National Neurological Societies , EAN has developed online Advocacy…
Development and Validation of a Clinical Score to Predict Epilepsy After Cerebral Venous Thrombosis
This study attempts to develop and externally validate a prognostic score to estimate the individual risk of postcerebral venous thrombosis epilepsy.
First Randomized Trial of IVIG for Autoimmune POTS Finds No Significant Effect : Neurology Today
An abstract is unavailable.
